Clinical Trials Logo

Endocarditis, Bacterial clinical trials

View clinical trials related to Endocarditis, Bacterial.

Filter by:

NCT ID: NCT02910856 Completed - Clinical trials for Infective Endocarditis

Infective Endocarditis in the Elderly

ELDERL-IE
Start date: March 2015
Phase:
Study type: Observational

ELDERL-IE is a multicenter national prospective observational study. The main objective is to describe geriatric characteristics (comorbidities, cognitive status, autonomy, nutritional status, balance and walking) in patients aged 75 years or older with infective endocarditis (IE). The secondary objectives are to assess the impact of geriatric features on the medico - surgical care and on morbidity and mortality at 3 months after the end of the hospitalization, and to describe the initial clinical presentation and diagnostic modalities in the IE elderly.

NCT ID: NCT02887079 Completed - Clinical trials for Infective Endocarditis

Research Interest Antiphospholipid in Predicting Embolic Risk During Infective Endocarditis

EMBOL-EI
Start date: January 1, 2014
Phase:
Study type: Observational

EMBOL-EI (Research Interest antiphospholipid antibody for embolic risk prediction in infective endocarditis) is a prospective cohort study with a biological collection. The main objective is: to re-evaluate the potential value of antiphospholipid (aPL) antibodies as predictors of embolic events in infective endocarditis (IE) in the light of the improved current knowledge on these aPL. The seconds objectives are: Other plasma biomarkers of hemostasis (coagulation activation markers: D-dimer fragment 1 + 2 of prothrombin; endothelial biomarkers: plasma levels of von Willebrand factor) will be taken into account in the analysis, and interest in predicting embolic risk, alone or in combination with aPL will be investigated.

NCT ID: NCT02816307 Completed - Clinical trials for Infective Endocarditis (IE)

Etiology of Endocarditis in Negative Blood Cultures

ENDOC
Start date: June 7, 2013
Phase: N/A
Study type: Interventional

Infective endocarditis remains a serious disease that requires fast and specialized support in 2012. However, 24% of endocarditis unanswered etiology. The systematic use of new policy diagnosis, including (i) a systematic use of specific PCR techniques and (ii) the search for markers of inflammatory and tumoral diseases, should increase the number of positive etiological diagnosis of culture-negative samples. Secondly, because of the seriousness of the disease, the investigators were led to develop a new score: score for admission. This score, realized in less than 4 hours from the admission of the suspected patient with endocarditis, should allow for immediate probabilistic antibiotic treatment after completion of the diagnostic kit. The modified Duke score give its results in 4 to 7 days. With the score of admission thus diagnostic processes are accelerated and, where appropriate, empirical antibiotic therapy started. Primary: Evaluate the effectiveness of the new diagnostic strategy on etiological identification of endocarditis. Secondary: Validate the "admission" score compared to the modified Duke score.

NCT ID: NCT02727413 Completed - Clinical trials for Valvular Heart Disease

Inflammatory Mediator Profiles During Heart Valve Replacement Surgery

Remove-Pilot
Start date: June 2016
Phase:
Study type: Observational

The study aims at the comparative examination of pre-, intra- and post-operative release profiles of inflammatory and vasoactive mediators in patients undergoing heart valve surgery under cardiopulmonary bypass (CPB) due to either infectious endocarditis or degenerative valvular heart disease. Specific attention will focus on the distinction between mediator release associated with infection and that resulting from CPB. Concomitantly identification and characterization of infectious pathogens in the circulation and in valvular samples will be carried out, together with the search for resistance-coding transcripts.

NCT ID: NCT02466139 Completed - Clinical trials for Infective Endocarditis

Early Clinical, Laboratory and Microbiological Predictors of Treatment Outcomes in Infective Endocaridtis

CRP-IE
Start date: April 2012
Phase: N/A
Study type: Observational [Patient Registry]

The investigators conduct a prospective observational study on consecutive patients being admitted to a tertiary care-centre with infective endocarditis. The investigators' primary aim is to identify baseline clincal, laboratory and microbiological predictors of in-hospital events, mortality and 6-month mortality.

NCT ID: NCT02287792 Completed - Clinical trials for Infective Endocarditis

18-FDG PET/CT Imaging and Clinical Decisions in Infective Endocarditis

TEPvENDO
Start date: April 17, 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the impact of 18-FDG positron emission tomography (PET)/computed tomography (CT) imaging in the management of patients with suspected or proven IE in detecting cardiac valve damages and other extracardiac complications. The study will evaluate whether this procedure can change the clinical decisions (treatments, valve surgery, patients' overall care) and modify the diagnosis of IE.

NCT ID: NCT01920126 Completed - Acute Kidney Injury Clinical Trials

The Effect of Sodium Bicarbonate on Postoperative Renal Function in Infective Endocarditis Patients Undergoing Open Heart Surgery

Start date: August 13, 2013
Phase: Phase 4
Study type: Interventional

The purpose of study is to test whether perioperative sodium bicarbonate infusion can prevent acute kidney injury following open heart surgery in infective endocarditis patients.

NCT ID: NCT01731483 Completed - Clinical trials for Infective Endocarditis

Coagulation and Fibrinolysis as Virulence Factors for Invasive Staphylococcus Aureus and Streptococcus Infections

Start date: July 2012
Phase:
Study type: Observational

the aim of this study is to investigate the role of staphylokinase, streptokinase and MMP activation in invasive staphylococcal and streptococcal infections.

NCT ID: NCT01512615 Completed - Clinical trials for Infective Endocarditis

CopenHeart IE - Integrated Rehabilitation of Patients Treated for Infective Endocarditis

Start date: December 2011
Phase: N/A
Study type: Interventional

The aim of the study is to describe the effect and meaning of an integrated rehabilitation programme, consisting of physical training and psycho-educational care, for patients treated for infective endocarditis. The hypothesis is, that integrated rehabilitation can improve mental health, physical capacity and other factors.

NCT ID: NCT00947817 Completed - Clinical trials for Infective Endocarditis

Impact of Endothelial Cell Activation and Modifications of Haemostasis Induced by Infective Endocarditis on the Risk of Embolism

Start date: September 2008
Phase: N/A
Study type: Interventional

Prospective study including all the consecutive patients admitted at the Department of Cardiology, Timone Hospital wih a definite diagnosis of IE according to the modified Duke criteria. The period of inclusion will be for 24 months. Eighty patients and age-matched control subject will be included. Primary end point are EE occurring during the antimicrobial treatment and secondary end points will be 6-month mortality, vegetation length and the impact of antimicrobial treatment on inflammation-induced procoagulant changes and endothelial cell activation.